Clinical Trial Update: A Study of Biweekly Gemcitabine, Paclitaxel, and Avastin in Patients With Metastatic Breast Cancer [Phase 2]

View source ↗

Summary

Phase 2 study evaluating a biweekly combination of gemcitabine, paclitaxel, and bevacizumab for metastatic breast cancer has completed and results were posted i…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• Avastin (bevacizumab)
• Gemzar (gemcitabine)
• Taxol (paclitaxel)

Snippet

Sponsor: Barbara Ann Karmanos Cancer Institute | Conditions: Metastatic Breast Cancer | Phase 2 | Status: COMPLETED | Results posted: 2017-04-14